Smithsonian reporter Corryn Wetzel spotlights how MIT researchers have developed a new technology inspired by camel fur that could be used to keep food and medical supplies chilled. The researchers hope the new system could be applied to “lots of areas that require passive cooling—meaning no external energy needs to power the process. Possible applications include insulating food storage, medical supplies and buildings.”
MIT researchers have created a new material that mimics camel fur and could be used to help keep food and medical supplies cool without electricity, reports Layal Liverpool for New Scientist. “We achieve evaporation and insulation at the same time, extending the cooling period significantly,” explains Prof. Jeffrey Grossman.
MIT researchers have developed a heated, reusable mask that could help filter out viruses such as Covid-19, reports Kayla Rivas for Fox News. “The contraption is said to slow particles down and inactivate viruses in mere seconds by the mesh and temperatures reaching 90°C, or 194°F,” writes Rivas.
CNBC reporter Charlie Wood features tProf. Connor Coley's work developing a new system that could be used to help automate molecule manufacturing. “It tries to understand, based on those patterns, what kind of transformations should work for new molecules it’s never seen before,” says Coley.
STAT reporter Elizabeth Cooney spotlights a new working paper by Profs. Martin Bazant and John Bush that explores the risk of airborne transmission of Covid-19. “Depending on ventilation, mask use, air filtration, and other variables, any indoor space may carry either low or high risk of transmission,” Bazant explains.
Scientific American reporter Robin Lloyd spotlights how MIT researchers have developed a new app that “allows users to adjust parameters such as mask usage, ventilation, and room size to estimate the indoor transmission risk for SARS-CoV-2 among a given number of people in various types of spaces.”
Writing for Scientific American, Carolyn Barber spotlights how researchers from MIT are developing cheap, fast and easy to use diagnostics for Covid-19 that can deliver results in minutes. “They are called lateral flow assays, but manifestly they are paper-strip tests that have an antibody embedded on filter paper,” writes Barber. “If a saliva sample has coronavirus present, the antibody will bind that viral antigen, turning the test positive, much like a pregnancy test works.”
Reporting for USA Today, Karen Weintraub spotlights how researchers from MIT and 3M are collaborating on a rapid, low-cost diagnostic test for Covid-19. "The world needs as many useful tests as possible as fast as possible," says Prof. Hadley Sikes.
CNBC reporter Will Feur spotlights how researchers from MIT are working with 3M on developing a rapid coronavirus antigen test. The test “will be a paper-based point-of-care testing device, which will help reduce the cost,” Feur explains.
Researchers from MIT and 3M are developing a new rapid antigen test for Covid-19, reports Carl O’Donnell for Reuters. “The test would produce results within minutes and could be administered on a low-cost, paper-based device, similar to a home pregnancy test, that could be delivered at the point of care,” writes O’Donnell.
TechCrunch reporter Darrell Etherington writes that researchers from MIT and 3M are working on creating a new diagnostic tool for Covid-19 that can be manufactured cheaply and in large volumes for mass distribution. “The goal is to create a test that detects viral antigens,” Etherington explains, adding that the tests “provide results much faster than the molecular PCR-based test.”
MIT researchers have developed a skin patch that could be used to fight melanoma, reports Berkeley Lovelace Jr. for CNBC. “Our patch technology could be used to deliver vaccines to combat different infectious diseases,” explains Prof. Paula Hammond. “But we are excited by the possibility that the patch is another tool in the oncologists’ arsenal against cancer, specifically melanoma.”
Writing for Science, Derek Lowe spotlights how MIT researchers are developing a platform that could be used to automate the production of molecules for use in medicine, solar energy and more. “The eventual hope is to unite the software and the hardware in this area,” reports Lowe, “and come up with a system that can produce new compounds with a minimum of human intervention.”
Dr. Francis Collins, director of the NIH, spotlights a video created by Prof. Kwanghun Chung that takes viewers on a voyage through a region of the brain that controls voluntary movement. Thanks to imaging techniques like Chung’s, “mapping the biocircuitry of the brain just keeps getting better all the time,” Collins explains.
Writing for the Financial Times about how technology is advancing the field of health care, John Browne spotlights Prof. Bob Langer’s work developing new methods of delivering drugs with improved precision. Browne explains that Langer is working on “a device smaller than a grain of rice that he can inject into a tumour to test the efficacy of dozens of chemotherapy agents in parallel.”